Skip to content
Home
About
Association Activities
Bylaws
History
Our Team
Publications
CANNT Journal
Open Access Articles
CANNT Connection Newsletters
Standards of Practice
Membership
Membership
Become a Member
Events
Upcoming Events/Webinars
Past Events
Virtual Conference Series
CANNT 2019 Annual Conference
CANNT Atlantic 2019
Certification
Resources
Annual Reports
AGM Minutes
CANNT Awards/ Bursaries
Career Opportunities
CEU Tests
My Course Dashboard
Conference Powerpoints
COVID-19 Resources
Webinars
My Course Dashboard
RALNO
LOGIN
Menu
Home
/
Courses
/ V29-1 The role of direct oral anticoagulants (DOACs) in hemodialysis
V29-1 The role of direct oral anticoagulants (DOACs) in hemodialysis
$
15.00
Add to cart
Category:
Courses
Related products
V30-3 Medical use of cannabis for patients with end stage kidney disease
$
15.00
Add to cart
V29-4 Health Disparities and Outcomes in Canadian Indigenous End-Stage Kidney Disease Patients
$
15.00
Add to cart
V29-3 Potassium Binding Agents: Patiromer and Sodium Zirconium Cycloscilicate
$
15.00
Add to cart
V25-S1 Vascular Access Guidelines
$
15.00
Add to cart